Abstract
The number of thymines in a thymine repeat in intron 8 (IVS8) next to the exon 9 of the cystic fibrosis gene (CFTR) affects the efficiency of this site to act as a splice acceptor site and the subsequent inclusion or skipping of exon 9 into the CFTR protein. Another source of genetic variation, responsible for mild cystic fibrosis (CF) and/or congenital bilateral absence of the vas deferens, is the mutation R117H, located in exon 4 of CFTR. Both these genetic variants can be detected using restriction site—generating PCR amplification. The severity of the CF phenotype is partly dependent on the IVS8 background on which R117H occurs; thus, it is important to be able to test clinically for both these variants. A method using restriction digestion of PCR product is presented.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chu C-S, Trapnell BC, Curristin S, Cutting GR, Crystal RG: Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993;3:151–156
Chillon M, Casals T, Mercier B, et al.: Mutations in the cystic fibrosis gene in patients with congenital bilateral absence of the vas deferens. N Engl J Med 1995;332:1475–1480
Costes M, Girodon E, Ghanem M, et al.: Frequentoccurrence of the CFTR intron 8 (TG)n 5T allele in men with CBAVD. Eur J Hum Genet 1995;3:285–293
Kieswetter S, Macek M, Davis C, et al.: A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993;5:274–278
Shrimpton AE, Borowitz D, Swender P: Cystic fibrosis mutation frequencies in upstate New York. Hum Mutat 1997;10:436–442
Zielenski J, Bozon D, Kerem B, et al.: Identification of mutations in exon 1 through 8 of cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991;10:229–235
Tsui L-C: The spectrum of cystic fibrosis mutations. Trends Genet 1992;8:392–398
Witt DR, Blumberg B, Schaefer C, et al.: Cystic fibrosis carrier screening in a prenatal population. Am J Hum Genet 1992;51:A16 (abstr)
Friedman KJ, Heim RA, Knowles MR, Silverman LM: Rapid characterization of the variable length polythymine tract in the cystic fibrosis (CFTR) gene: Association of the IVS8-5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease. Hum Mutat 1997;10:108–115
Chmiel J, Drumm ML, Konstan MW, Ferkol TW, Kercsmar CM: Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis. Pediatrics 1999;103:823–826
Dean M, et al.: Multiple mutations in highly conserved residues are found in mildly affected CF patients. Cell 1990;61:863–870
Feldman D, Sardet A, Cougoureux E, et al.: Identification of three novel mutations in the CFTR gene, R117P, delta D192 and 3121+1GA in four French patients. Hum Mutat 1998;(Suppl 1)S78-S80
Ferec C, Novelli G, Verlingue C, et al.: Identification of six novel CFTR mutations in a sample of Italian CF patients. Mol Cell Probes 1995;9:135–137
Chevalier-Porst F, Chomel JC, Hillaire D, et al.: A nonsense mutation in exon 4 of the CF gene frequent amongst the population of the Reunion Island. Hum Mol Genet 1992;1:647–649
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shrimpton, A.E. R117H and IVS8-5T Cystic Fibrosis Mutation Detection by Restriction Enzyme Digestion. Molecular Diagnosis 5, 235–238 (2000). https://doi.org/10.1007/BF03262081
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03262081